{"id":59134,"date":"2021-12-29T11:05:07","date_gmt":"2021-12-29T11:05:07","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=84639"},"modified":"2021-12-29T11:05:07","modified_gmt":"2021-12-29T11:05:07","slug":"seegene-airlifts-1-7-million-covid-19-tests-to-israel-battling-the-omicron-variant-by-a-charter-plane","status":"publish","type":"post","link":"https:\/\/kuwaitnewsgazette.com\/seegene-airlifts-1-7-million-covid-19-tests-to-israel-battling-the-omicron-variant-by-a-charter-plane\/","title":{"rendered":"Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a charter plane"},"content":{"rendered":"
SEOUL, South Korea, Dec. 29, 2021 \/PRNewswire\/ —\u00a0Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, today announced it will deliver COVID-19 testing reagents by a private plane to Israel that is experiencing acute shortages related to the resurgence of new cases due to the Omicron variant. A total of 1.7 million Allplex™ SARS-CoV-2 Master Assays and associated consumables will be sent on December 29.<\/p>\n
Seegene’s Allplex™ SARS-CoV-2 Master Assay can determine whether a person is infected with the SARS-CoV-2 virus and if he\/she has contracted the Omicron variant. It targets four genes (E, RdRP, N, and S), along with five mutations: HV69\/70 deletion, Y144 deletion, E484K, N501Y, P681H. Among these, HV69\/70, N501Y, and P681H signal the presence of Omicron, based on the variants circulating right now. According to clinical research in a South African lab, the test results using Allplex™ SARS-CoV-2 Master Assay matched 100% with the results drawn out from additional sequencing, confirming that the test can accurately detect Omicron.<\/p>\n
This is the second emergency shipment to Israel; the first was in April 2020. This time, the plane was hired Seegene’s Israeli partner, HY Laboratories, as they look to support the country’s current demand.<\/p>\n
On December 19, the company also hired a private plane to deliver 2.8 million COVID-19 tests to European countries including Italy, Spain, Belgium, Czechia, and Lithuania as the number of new infections has surged due to the emergence of Omicron.<\/p>\n
“Demand for tests has soared dramatically following the emergence and rapid spread of the Omicron variant,” said Dr. Jong-Yoon\u00a0Chun, Seegene Founder and CEO. “Although the expense and effort of the charter planes may seem extreme, we believe it’s both a priority and our responsibility to support the global fight against the pandemic. We hope we can be of help to all of these countries.”<\/p>\n
Seegene Inc.
\nJessica Park
\nP: +82-2-2240-0
\nE: jypark2@seegene.com<\/a><\/p>\n